Reported 1 day ago
Pfizer's stock rose 3.1% on Monday morning, fueled by reports of a $1 billion investment from activist investor Starboard Value. After a significant decline in stock value post-pandemic, Starboard's involvement aims to aid Pfizer's turnaround following challenges from decreasing vaccine sales and late entries into lucrative markets. Although Pfizer plans to cut costs and has approached former executives for advice, the company's current position prompts questions about its recovery and potential as an investment.
Source: YAHOO